Sort   by:  
 Page size 
UnknownA cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease.
Not available
S-EPMC7002703 | biostudies-literature
UnknownResveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.
Not available
S-EPMC8958504 | biostudies-literature
UnknownReal-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study.
Not available
S-EPMC12596416 | biostudies-literature
UnknownMechanical power is not associated with mortality in COVID-19 mechanically ventilated patients.
Not available
S-EPMC11861844 | biostudies-literature
UnknownLong-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Not available
S-EPMC11879157 | biostudies-literature
UnknownClustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort.
Not available
S-EPMC10958830 | biostudies-literature
UnknownImpact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Not available
S-EPMC10388269 | biostudies-literature
UnknownKey Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
Not available
S-EPMC9824938 | biostudies-literature
UnknownQuality improvement collaborative for improving patient care delivery in Argentine public health sector intensive care units.
Not available
S-EPMC11149125 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
Sort   by:  
 Page size